Ken Griffin Clear Point Neuro, Inc. Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 79,569 shares of CLPT stock, worth $838,657. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,569

Previous 52,300 52.14%

Holding current value

$838,657

Previous $621,000 52.98%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$10.51 - $14.71 $707,953 - $990,865	67,360 Added 551.72%	79,569 $950,000
Q1 2025 May 15, 2025	SELL	$11.89 - $18.8 $154,201 - $243,817	-12,969 Reduced 51.51%	12,209 $145,000
Q4 2024 Feb 14, 2025	SELL	$10.74 - $16.68 $652,304 - $1.01 Million	-60,736 Reduced 70.69%	25,178 $387,000
Q3 2024 Nov 14, 2024	SELL	$5.3 - $13.18 $525,113 - $1.31 Million	-99,078 Reduced 53.56%	85,914 $963,000
Q2 2024 Aug 14, 2024	BUY	$5.25 - $6.73 $578,634 - $741,753	110,216 Added 147.39%	184,992 $997,000
Q1 2024 May 15, 2024	BUY	$6.03 - $7.86 $281,956 - $367,525	46,759 Added 166.9%	74,776 $508,000
Q4 2023 Feb 14, 2024	SELL	$4.46 - $7.07 $259,531 - $411,410	-58,191 Reduced 67.5%	28,017 $190,000
Q3 2023 Nov 14, 2023	SELL	$5.01 - $7.09 $88,707 - $125,535	-17,706 Reduced 17.04%	86,208 $431,000
Q2 2023 Aug 14, 2023	BUY	$6.54 - $10.58 $196,043 - $317,146	29,976 Added 40.54%	103,914 $752,000
Q1 2023 May 15, 2023	SELL	$7.33 - $10.63 $373,844 - $542,151	-51,002 Reduced 40.82%	73,938 $624,000
Q4 2022 Feb 14, 2023	BUY	$7.7 - $11.21 $755,870 - $1.1 Million	98,165 Added 366.63%	124,940 $1.06 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $16.49 $81,918 - $137,559	-8,342 Reduced 23.75%	26,775 $277,000

Others Institutions Holding CLPT

# of Institutions

102

Shares Held

7.91M

Call Options Held

116K

Put Options Held

46.8K

View Full List

About ClearPoint Neuro, Inc.

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $258M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

More about CLPT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account